For people with chronic migraine, taking glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, for other conditions such as diabetes and weight loss, was associated with fewer emergency ...

Weight loss drugs have been linked to lowering the risk of many serious conditions, including dementia. Now, experts are ...

Doctors break it down.

While GLP-1 receptor agonists were initiated for other health reasons, they were tied to less need for migraine prevention medications.

Talk about a surprise perk. Numerous additional benefits of GLP-1 weight loss drugs like Ozempic continue to be discovered, ...

Preliminary study finds GLP-1 drugs (semaglutide, etc.) are associated with 10% fewer emergency visits and lower medication use for chronic migraine patients.

Findings showed 12.1% of atogepant-treated patients discontinued treatment due to adverse events compared with 29.6% of topiramate-treated patients. Topline results were announced from a phase 3 trial ...

Can the neurovascular effects of GLP-1s play a role in treating migraine?

NEW YORK (Reuters Health) - Topiramate is safe and effective in preventing migraine in 12- to 17-year-old patients, according to a report in the journal Pediatrics. While topiramate is FDA-approved ...

Please provide your email address to receive an email when new articles are posted on . Patients had a history of 4 or more migraine days each month. Doses included 60 mg of atogepant or the maximum ...

The Consumer Justice Foundation, a free online resource designed to provide consumers with information regarding how they should deal with large corporations that include pharmaceutical drug companies ...

Topiramate, a drug for migraine prophylaxis, may have beneficial effects on the kidneys. Migraine treatment with topiramate is linked to lower risks of end-stage kidney disease (ESKD), death, and ...